Catamount Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-84
Closed -$7K 206
2018
Q4
$7K Buy
+84
New +$7.85K ﹤0.01% 145
2016
Q4
Sell
-103
Closed -$9K 178
2016
Q3
$9K Hold
103
0.01% 115
2016
Q2
$9K Hold
103
0.01% 99
2016
Q1
$8K Hold
103
0.01% 98
2015
Q4
$8K Hold
103
0.01% 95
2015
Q3
$7K Hold
103
0.01% 99
2015
Q2
$8K Hold
103
0.01% 122
2015
Q1
$8K Buy
103
+3
+3% +$227 0.01% 107
2014
Q4
$7K Buy
+100
New +$6.95K 0.01% 98

Other funds holding MDT

Catamount Wealth Management's MDT Position: Q1 2019 in Review

Catamount Wealth Management sold out of Medtronic (MDT) in Q1 2019, closing a stake of 84 shares — an estimated $7K sold.

Catamount Wealth Management first reported a position in MDT in Q4 2014 and held it in 9 quarters. The position peaked at $9K in Q3 2016. 1,602 funds tracked by Wall St. Rank hold MDT as of Q1 2019.

  • Catamount Wealth Management reported no remaining Medtronic position as of Q1 2019 after selling out during the quarter.
  • Catamount Wealth Management sold 84 Medtronic shares in Q1 2019, an estimated $7K.
  • Catamount Wealth Management first reported a position in Medtronic in Q4 2014 and held it in 9 quarters.
  • Catamount Wealth Management's Medtronic position peaked at $9K in Q3 2016.
  • 1,602 funds tracked by Wall St. Rank held Medtronic as of Q1 2019.

Based on Catamount Wealth Management's 13F filing for Q1 2019, filed 3 May 2019.